The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations Valentina FrancoPavel GershkovichMeir Bialer Current Opinion 12 August 2020 Pages: 1493 - 1500
Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib Stefanie L. GroenlandAlejandra Martínez-ChávezNeeltje Steeghs Review Article 08 October 2020 Pages: 1501 - 1520
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action Ellen J. B. DerissenJos H. Beijnen Review Article Open access 16 October 2020 Pages: 1521 - 1550
Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019 Pieter-Jan De SutterElke GasthuysAn Vermeulen Systematic Review 18 August 2020 Pages: 1551 - 1573
Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study Ahmed A. MahmoudSean N. AvedissianMarc H. Scheetz Original Research Article 28 May 2020 Pages: 1575 - 1587
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial Helle LinnebjergQianyi ZhangJennifer Leohr Original Research Article Open access 29 May 2020 Pages: 1589 - 1599
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study Jennifer LeohrMary Anne DellvaHelle Linnebjerg Original Research Article Open access 29 May 2020 Pages: 1601 - 1610
Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A Sylvie RetoutChristophe SchmittNicolas Frey Original Research Article Open access 05 June 2020 Pages: 1611 - 1625
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine Sabrina T. WiebeThomas GiessmannPeter Stopfer Original Research Article Open access 05 June 2020 Pages: 1627 - 1639
Comment on “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab” Jialing LiuAliza Anwar MemonAndrew Siedlecki Letter to the Editor 28 October 2020 Pages: 1641 - 1643
Author’s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab” Kioa Lente WijnsmaRob ter HeineRoger J. Brüggemann Letter to the Editor 28 October 2020 Pages: 1645 - 1646
Correction to: Drug–Drug Interactions with Direct Oral Anticoagulants Kathrin I. FoersterSimon HermannWalter E. Haefeli Correction Open access 30 October 2020 Pages: 1647 - 1647
